• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9010
Medical Device Problem Codes Obstruction of Flow (2423); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hematoma (1884); Thrombosis/Thrombus (4440); Restenosis (4576); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 04/23/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through the results of a clinical trial (b)(4) that approximately sometimes post index procedure using a lutonix drug-coated balloon catheter in the cephalic vein for target lesion stenosis, the subject had an adverse event of hematoma and steal syndrome.The adverse event relationship to the device, procedure and arteriovenous access circuit was not reported.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H11: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.Section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed and this lot met all release criteria.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.D4 (unique identifier (udi) #), g3, h6 (device, component, method).Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the results of a clinical trial (av pas / (b)(6)) that approximately sometimes post index procedure using a lutonix drug-coated balloon catheter in the cephalic vein for target lesion stenosis, the subject had an adverse event of hematoma and steal syndrome.The adverse event relationship to the device, procedure and arteriovenous access circuit was not reported.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed, and this lot met all release criteria.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, e1, g3, h6 (patient).Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the results of a clinical trial (av pas/cl003301) that approximately two months three weeks and five days post index procedure using a lutonix drug-coated balloon catheter in the cephalic vein for target lesion stenosis, the subject had an adverse event of target lesion restenosis.It was further reported that the subject reportedly diagnosed with hematoma and steal syndrome.Additionally, the patient had arm swelling and thrombosis was identified at the access site.The current status of the patient is unknown.
 
Event or Problem Description
It was reported through the results of a clinical trial ((b)(4)) that approximately two months three weeks and five days post index procedure using a lutonix drug-coated balloon catheter in the cephalic vein for target lesion stenosis, the subject had an adverse event of target lesion restenosis.It was further reported that the subject reportedly diagnosed with hematoma and steal syndrome.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed, and this lot met all release criteria.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, b7, g3, h6 (patient).Section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035AV DRUG COATED PTA DILATION CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope MN 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key22781642
Report Number3006513822-2025-00058
Device Sequence Number9906803
Product Code PRC
UDI-Device Identifier00801741135347
UDI-Public(01)00801741135347(11)230224(17)260115(10)GFGZ1944
Combination Product (Y/N)Y
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P170003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 10/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/15/2026
Device Model Number9010
Device Catalogue NumberLX3575540V
Device Lot NumberGFGZ1944
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/16/2025
Supplement Date Received by Manufacturer08/26/2025
10/01/2025
10/22/2025
Initial Report FDA Received Date08/12/2025
Supplement Report FDA Received Date09/10/2025
10/06/2025
10/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/24/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient Weight76 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-